Patents by Inventor Daniel Shin

Daniel Shin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12597484
    Abstract: Systems and methods are provided for trait prediction coordination. One embodiment is a method that includes launching a genomics application at a user device, receiving a command to present a partner application within the genomics application, selecting characteristics to predict for an individual, based on an identifier that distinguishes the partner application from other partner applications, operating polygenic models that generate predictions for the characteristics based on genetic records for the individual, acquiring media for the partner application, based on the predictions, and operating the partner application to update a display at the user device with the media, thereby providing the predictions in a format specific to the partner application.
    Type: Grant
    Filed: August 10, 2020
    Date of Patent: April 7, 2026
    Assignee: Helix, Inc.
    Inventors: Ryan Trunck, Rani Powers, Christopher M. Glode, Stewart Blanford, Daniel Shin
  • Publication number: 20260001911
    Abstract: Provided are novel piperazic acid containing peptide compound stereoisomer, solvate, or pharmaceutically acceptable salt thereof, method of preparing the same, and use thereof. The peptide compound, stereoisomer, solvate, or pharmaceutically acceptable salt thereof has activities of anticancer, anti-metastasis, and growth inhibition of resistant tumors, and thus may be used to prevent or treat various cancers or metastases of cancer.
    Type: Application
    Filed: September 18, 2025
    Publication date: January 1, 2026
    Inventors: Dong-Chan OH, Daniel SHIN, Sang Kook LEE, Woong Sub BYUN
  • Publication number: 20250134445
    Abstract: Aspects of the present disclosure relate to an apparatus for predicting an olfactory profile of a molecule, the apparatus comprising memory circuitry, machine-readable instructions, and processor circuitry to execute the machine-readable instructions to obtain a first representation of the molecule and a second representation of the molecule, process the first representation using at least one first machine-learning model to obtain a first predicted olfactory profile of the molecule, process the second representation using at least one second machine-learning model to obtain a second predicted olfactory profile of the molecule, process the first predicted olfactory profile and the second predicted olfactory profile, or a combined version of the first predicted olfactory profile and the second predicted olfactory profile, using a third machine-learning model, the third machine-learning model being trained to output a third predicted olfactory profile of the molecule.
    Type: Application
    Filed: October 25, 2023
    Publication date: May 1, 2025
    Applicant: Sony Group Corporation
    Inventors: Tarek Richard BESOLD, Priyadarshini KUMARI, Gao PEI, Daniel SHIN
  • Patent number: 12131317
    Abstract: In one embodiment, a method includes obtaining, by a payment service system, an amount of security assets via a securities exchange system. The method includes determining amounts of security assets owned by the payment service system and users of the payment service system. The method includes receiving, via an application of the payment service system executing on a device of a user of the payment service system, a request from the user to sell an amount of a security asset owned by the user. The method includes facilitating execution of a sale of the amount of security assets. The method includes, prior to the sale request settling, depositing, by the payment service system, a currency account of the user with an amount of funds associated with a determined value of the security asset requested to be sold by the user.
    Type: Grant
    Filed: June 10, 2022
    Date of Patent: October 29, 2024
    Assignee: Block, Inc.
    Inventors: Kristopher David Stipech, Ryan Budd, Daniel Shin, River Satya, Brian Grassadonia, Emily Chiu
  • Publication number: 20220402970
    Abstract: Provided are novel piperazic acid containing peptide compound stereoisomer, solvate, or pharmaceutically acceptable salt thereof, method of preparing the same, and use thereof. The peptide compound, stereoisomer, solvate, or pharmaceutically acceptable salt thereof has activities of anticancer, anti-metastasis, and growth inhibition of resistant tumors, and thus may be used to prevent or treat various cancers or metastases of cancer.
    Type: Application
    Filed: September 24, 2020
    Publication date: December 22, 2022
    Inventors: Dong-Chan OH, Daniel SHIN, Sang Kook LEE, Woong Sub BYUN
  • Publication number: 20220309493
    Abstract: In one embodiment, a method includes obtaining, by a payment service system, an amount of security assets via a securities exchange system. The method includes determining amounts of security assets owned by the payment service system and users of the payment service system. The method includes receiving, via an application of the payment service system executing on a device of a user of the payment service system, a request from the user to sell an amount of a security asset owned by the user. The method includes facilitating execution of a sale of the amount of security assets. The method includes, prior to the sale request settling, depositing, by the payment service system, a currency account of the user with an amount of funds associated with a determined value of the security asset requested to be sold by the user.
    Type: Application
    Filed: June 10, 2022
    Publication date: September 29, 2022
    Inventors: Kristopher David Stipech, Ryan Budd, Daniel Shin, River Satya, Brian Grassadonia, Emily Chiu
  • Publication number: 20200372970
    Abstract: Systems and methods are provided for trait prediction coordination. One embodiment is a method that includes launching a genomics application at a user device, receiving a command to present a partner application within the genomics application, selecting characteristics to predict for an individual, based on an identifier that distinguishes the partner application from other partner applications, operating polygenic models that generate predictions for the characteristics based on genetic records for the individual, acquiring media for the partner application, based on the predictions, and operating the partner application to update a display at the user device with the media, thereby providing the predictions in a format specific to the partner application.
    Type: Application
    Filed: August 10, 2020
    Publication date: November 26, 2020
    Inventors: Ryan Trunck, Rani Powers, Christopher M. Glode, Stewart Blanford, Daniel Shin
  • Patent number: 10777300
    Abstract: Systems and methods are provided for trait prediction coordination. One embodiment is a method that includes launching a genomics application at a user device, receiving a command to present a partner application within the genomics application, selecting characteristics to predict for an individual, based on an identifier that distinguishes the partner application from other partner applications, operating polygenic models that generate predictions for the characteristics based on genetic records for the individual, acquiring media for the partner application, based on the predictions, and operating the partner application to update a display at the user device with the media, thereby providing the predictions in a format specific to the partner application.
    Type: Grant
    Filed: February 28, 2019
    Date of Patent: September 15, 2020
    Assignee: HELIX OPCO, LLC
    Inventors: Ryan Trunck, Rani Powers, Christopher M. Glode, Stewart Blanford, Daniel Shin
  • Patent number: 10711312
    Abstract: Disclosed herein are methods of treating or assessing cancer in a subject wherein it has been determined whether the cancer comprises a loss of function mutation or disruption in an immune pathway. The loss of function mutation or disruption can be in JAK1 or JAK2. The loss of function mutation or disruption can be in B2M. The methods can include administering an immune checkpoint therapy such as anti-PD1 or anti-PDL1. The methods can include administering an alternative therapy to an immune checkpoint therapy. In some aspects, the method includes determining whether the cancer comprises a loss of function mutation or disruption in an immune pathway.
    Type: Grant
    Filed: July 12, 2017
    Date of Patent: July 14, 2020
    Assignee: The Regents of the University of California
    Inventors: Antoni Ribas, Jesse Zaretsky, Daniel Shin, Angel Garcia-Diaz, Blanca Homet Moreno
  • Publication number: 20200105366
    Abstract: Systems and methods are provided for trait prediction coordination. One embodiment is a method that includes launching a genomics application at a user device, receiving a command to present a partner application within the genomics application, selecting characteristics to predict for an individual, based on an identifier that distinguishes the partner application from other partner applications, operating polygenic models that generate predictions for the characteristics based on genetic records for the individual, acquiring media for the partner application, based on the predictions, and operating the partner application to update a display at the user device with the media, thereby providing the predictions in a format specific to the partner application.
    Type: Application
    Filed: February 28, 2019
    Publication date: April 2, 2020
    Inventors: Ryan Trunck, Rani Powers, Christopher M. Glode, Stewart Blanford, Daniel Shin
  • Publication number: 20180051347
    Abstract: Disclosed herein are methods of treating or assessing cancer in a subject wherein it has been determined whether the cancer comprises a loss of function mutation or disruption in an immune pathway. The loss of function mutation or disruption can be in JAK1 or JAK2. The loss of function mutation or disruption can be in B2M. The methods can include administering an immune checkpoint therapy such as anti-PD1 or anti-PDL1. The methods can include administering an alternative therapy to an immune checkpoint therapy. In some aspects, the method includes determining whether the cancer comprises a loss of function mutation or disruption in an immune pathway.
    Type: Application
    Filed: July 12, 2017
    Publication date: February 22, 2018
    Inventors: Antoni Ribas, Jesse Zaretsky, Daniel Shin, Angel Garcia-Diaz, Blanca Homet Moreno
  • Publication number: 20060233649
    Abstract: Thin film shape memory alloy (SMA) micro pump that has high work density and high frequency response. A miniature SMA pump is used to rectify liquid to achieve stroke. Controlled fluid flow provides forced convection cooling on the SMA membrane that allows the micro pump to operate at high operational frequencies and high work density.
    Type: Application
    Filed: April 15, 2004
    Publication date: October 19, 2006
    Applicant: The Regents of the University of California
    Inventors: Gregory Carman, Daniel Shin
  • Patent number: D846496
    Type: Grant
    Filed: May 15, 2017
    Date of Patent: April 23, 2019
    Assignee: SPIGEN KOREA CO., LTD.
    Inventors: Daniel Shin, Ye Ri Han
  • Patent number: D853957
    Type: Grant
    Filed: May 12, 2017
    Date of Patent: July 16, 2019
    Assignee: SPIGEN KOREA CO., LTD.
    Inventors: Daniel Shin, Ye Ri Han
  • Patent number: D966318
    Type: Grant
    Filed: July 28, 2021
    Date of Patent: October 11, 2022
    Assignee: Block, Inc.
    Inventors: Kristopher David Stipech, Ryan Budd, Daniel Shin, River Satya, Brian Grassadonia
  • Patent number: D1061588
    Type: Grant
    Filed: September 6, 2022
    Date of Patent: February 11, 2025
    Assignee: Block, Inc.
    Inventors: Kristopher David Stipech, Ryan Budd, Brian Grassadonia, River Satya, Daniel Shin